Intestinal alkaline phosphatase at the crossroad of intestinal health and disease – a putative role in type 1 diabetes

Patients with type 1 diabetes have shown an increase in circulating cytokines, altered lipoprotein metabolism and signs of vascular dysfunction in response to high‐fat meals. Intestinal alkaline phosphatase (IAP) regulates lipid transport and inflammatory responses in the gastrointestinal tract. We therefore hypothesized that changes in IAP activity could have profound effects on gut metabolic homeostasis in patients with type 1 diabetes.

[1]  Ramchander Merugu,et al.  Human Alkaline phosphatases in health and disease: A mini review , 2016 .

[2]  R. Hodin,et al.  Intestinal Alkaline Phosphatase Regulates Tight Junction Protein Levels. , 2016, Journal of the American College of Surgeons.

[3]  H. Siljander,et al.  The role of the intestinal microbiota in type 1 diabetes mellitus , 2016, Nature Reviews Endocrinology.

[4]  M. S. Malo,et al.  A High Level of Intestinal Alkaline Phosphatase Is Protective Against Type 2 Diabetes Mellitus Irrespective of Obesity , 2015, EBioMedicine.

[5]  R. Strugnell,et al.  Increased Autoimmune Diabetes in pIgR-Deficient NOD Mice Is Due to a "Hitchhiking" Interval that Refines the Genetic Effect of Idd5.4 , 2015, PloS one.

[6]  D. Sanders,et al.  The relationship between inflammatory bowel disease and type 1 diabetes mellitus: a study of relative prevalence in comparison with population controls. , 2015, Journal of gastrointestinal and liver diseases : JGLD.

[7]  M. Taskinen,et al.  High-fat meals induce systemic cytokine release without evidence of endotoxemia-mediated cytokine production from circulating monocytes or myeloid dendritic cells , 2015, Acta Diabetologica.

[8]  Mehrbod Estaki,et al.  Interplay between intestinal alkaline phosphatase, diet, gut microbes and immunity. , 2014, World journal of gastroenterology.

[9]  B. Wang,et al.  Effect of γ-aminobutyric acid on digestive enzymes, absorption function, and immune function of intestinal mucosa in heat-stressed chicken. , 2014, Poultry science.

[10]  H. Sayles,et al.  Unique Antibody Responses to Malondialdehyde-Acetaldehyde (MAA)-Protein Adducts Predict Coronary Artery Disease , 2014, PloS one.

[11]  M. Taskinen,et al.  Patients with type 1 diabetes show signs of vascular dysfunction in response to multiple high-fat meals , 2014, Nutrition & Metabolism.

[12]  J. Gálvez.  Role of Th17 Cells in the Pathogenesis of Human IBD , 2014, ISRN inflammation.

[13]  R. Campos-Rodríguez,et al.  Stress modulates intestinal secretory immunoglobulin A , 2013, Front. Integr. Neurosci..

[14]  N. Kramer,et al.  A novel hypothesis for an alkaline phosphatase 'rescue' mechanism in the hepatic acute phase immune response. , 2013, Biochimica et biophysica acta.

[15]  T. Brusko,et al.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes. , 2013, Immunotherapy.

[16]  Chunguang Wang,et al.  Natural antibodies of newborns recognize oxidative stress-related malondialdehyde acetaldehyde adducts on apoptotic cells and atherosclerotic plaques. , 2013, International immunology.

[17]  J. Risteli,et al.  Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR-/- mice and bind plasma autoantibodies in humans under enhanced carbamylation. , 2013, Antioxidants & redox signaling.

[18]  Jan Verhaegen,et al.  A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis , 2013, Gut.

[19]  J. Millán,et al.  Intestinal alkaline phosphatase prevents metabolic syndrome in mice , 2013, Proceedings of the National Academy of Sciences.

[20]  B. Stockinger,et al.  TH17 cell plasticity in Peyer’s patches is responsible for induction of T cell-dependent IgA responses , 2013, Nature Immunology.

[21]  K. Kaukinen,et al.  Association study of FUT2 (rs601338) with celiac disease and inflammatory bowel disease in the Finnish population. , 2012, Tissue antigens.

[22]  C. Elson,et al.  Th17 Cells Upregulate Polymeric Ig Receptor and Intestinal IgA and Contribute to Intestinal Homeostasis , 2012, The Journal of Immunology.

[23]  M. Farkouh,et al.  Are patients with inflammatory bowel disease at increased risk of coronary artery disease? , 2012, The American journal of medicine.

[24]  G. Veres,et al.  Intestinal alkaline phosphatase in the colonic mucosa of children with inflammatory bowel disease. , 2012, World journal of gastroenterology.

[25]  Patrice D Cani,et al.  Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity , 2012, Gut microbes.

[26]  C. Ciacci,et al.  Butyrate Attenuates Lipopolysaccharide-Induced Inflammation in Intestinal Cells and Crohn's Mucosa through Modulation of Antioxidant Defense Machinery , 2012, PloS one.

[27]  G. Veres,et al.  Decreased mucosal expression of intestinal alkaline phosphatase in children with coeliac disease , 2012, Virchows Archiv.

[28]  K. Matsuo,et al.  ABO blood group alleles and the risk of pancreatic cancer in a Japanese population , 2011, Cancer science.

[29]  J. Ilonen,et al.  IL-17 Immunity in Human Type 1 Diabetes , 2010, The Journal of Immunology.

[30]  J. Lallès.  Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. , 2010, Nutrition reviews.

[31]  R. Pieters,et al.  Intestinal alkaline phosphatase contributes to the reduction of severe intestinal epithelial damage. , 2010, European journal of pharmacology.

[32]  B. Cheung,et al.  Association between serum alkaline phosphatase and C-reactive protein in the United States National Health and Nutrition Examination Survey 2005–2006 , 2010, Clinical chemistry and laboratory medicine.

[33]  J. Bertranpetit,et al.  A natural history of FUT2 polymorphism in humans. , 2009, Molecular biology and evolution.

[34]  Q. Sun,et al.  Impaired intestinal mucosal immunity in specific-pathogen-free chickens after infection with very virulent infectious bursal disease virus. , 2009, Poultry science.

[35]  C. Forsblom,et al.  Serum Lipopolysaccharide Activity Is Associated With the Progression of Kidney Disease in Finnish Patients With Type 1 Diabetes , 2009, Diabetes Care.

[36]  H. Rautelin,et al.  Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis , 2009, Annals of medicine.

[37]  J. Salonen,et al.  Serum Matrix Metalloproteinase-8 Concentrations Are Associated With Cardiovascular Outcome in Men , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[38]  M. Matsushita,et al.  Involvement of intestinal alkaline phosphatase in serum apolipoprotein B-48 level and its association with ABO and secretor blood group types. , 2006, Biochemical and biophysical research communications.

[39]  W. Markiewicz,et al.  Association Between Elevated Liver Enzymes and C-Reactive Protein: Possible Hepatic Contribution to Systemic Inflammation in the Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[40]  C. Forsblom,et al.  Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients , 2003, Diabetologia.

[41]  J. Witztum,et al.  Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis , 2000, Journal of internal medicine.

[42]  M. Matsushita,et al.  Changes in intestinal alkaline phosphatase isoforms in healthy subjects bearing the blood group secretor and non-secretor. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[43]  V. Godfrey,et al.  Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. , 1995, Journal of immunology.

[44]  T. Stigbrand,et al.  Serum levels of human alkaline phosphatase isozymes in relation to blood groups. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[45]  D. Lafrenz,et al.  Alkaline phosphatase on activated B cells characterization of the expression of alkaline phosphatase on activated B cells. Kinetics and membrane anchor. , 1991, Journal of immunology.

[46]  M. Toribio,et al.  Expression of alkaline phosphatase in murine B lymphocytes. Correlation with B cell differentiation into Ig secretion. , 1989, Journal of immunology.

[47]  D. Burg,et al.  Late events in B cell activation. Expression of membrane alkaline phosphatase activity. , 1989, Journal of immunology.

[48]  P. Bayer,et al.  Intestinal alkaline phosphatase and the ABO blood group system--a new aspect. , 1980, Clinica chimica acta; international journal of clinical chemistry.

[49]  R. Ducluzeau,et al.  Increase in the Population of Duodenal Immunoglobulin A Plasmocytes in Axenic Mice Associated with Different Living or Dead Bacterial Strains of Intestinal Origin , 1978, Infection and immunity.

[50]  J. Shaw,et al.  Glycemic control and excess mortality in type 1 diabetes. , 2015, The New England journal of medicine.

[51]  M. Claesson,et al.  Interactions between infections and immune-inflammatory cells in type 1 diabetes mellitus and inflammatory bowel diseases: evidences from animal models. , 2008, Clinical and experimental rheumatology.

[52]  松下 誠.  Changes in intestinal alkaline phosphatase isoforms in healthy subjects bearing the blood group secretor and non-secretor , 1998 .